1BSL01AE — Biotika as Cashflow Statement
0.000.00%
Last trade - 00:00- €5.39m
- €3.86m
- €12.15m
Annual cashflow statement for Biotika as, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.73 | 0.515 | -0.843 | 0.221 | -2.83 |
| Depreciation | |||||
| Non-Cash Items | -0.796 | -0.317 | -0.227 | -0.252 | -0.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.17 | -3.5 | -0.169 | 0.279 | 0.283 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.89 | -1.67 | 0.286 | 1.73 | -1.68 |
| Capital Expenditures | -1.47 | -0.251 | -0.703 | -1.09 | -0.884 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.093 | -0.877 | 0.444 | 0.295 | 0.726 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.37 | -1.13 | -0.259 | -0.796 | -0.158 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.914 | -0.202 | -0.192 | 0 | -0.04 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.589 | -2.99 | -0.166 | 0.946 | -1.86 |